149 related articles for article (PubMed ID: 36268280)
1. Mining Database to Identify Aging-Related Molecular Subtype and Prognostic Signature in Lung Adenocarcinoma.
Feng C; Che W; Liang H; Zhang H; Lan C; Wu B; Lin W; Chen Y
J Oncol; 2022; 2022():9142903. PubMed ID: 36268280
[TBL] [Abstract][Full Text] [Related]
2. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma.
Hu J; Wang T; Chen Q
Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of molecular subtype and prognostic signature for lung adenocarcinoma based on neutrophil extracellular traps.
Zuo Y; Leng G; Leng P
Pathol Oncol Res; 2023; 29():1610899. PubMed ID: 37143472
[No Abstract] [Full Text] [Related]
4. Prognostic Value of Genomic Instability of m
Li R; Li JP; Liu TT; Huo C; Yao J; Ji XL; Qu YQ
Front Cell Dev Biol; 2022; 10():707405. PubMed ID: 35309906
[No Abstract] [Full Text] [Related]
5. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive bioinformatics analysis to identify a novel cuproptosis-related prognostic signature and its ceRNA regulatory axis and candidate traditional Chinese medicine active ingredients in lung adenocarcinoma.
Wang S; Xing N; Meng X; Xiang L; Zhang Y
Front Pharmacol; 2022; 13():971867. PubMed ID: 36110528
[TBL] [Abstract][Full Text] [Related]
7. A Seven-Long Non-coding RNA Signature Improves Prognosis Prediction of Lung Adenocarcinoma: An Integrated Competing Endogenous RNA Network Analysis.
Li R; Han K; Xu D; Chen X; Lan S; Liao Y; Sun S; Rao S
Front Genet; 2020; 11():625977. PubMed ID: 33584817
[TBL] [Abstract][Full Text] [Related]
8. Identification of a Prognostic Signature Composed of GPI, IL22RA1, CCT6A and SPOCK1 for Lung Adenocarcinoma Based on Bioinformatic Analysis of lncRNA-Mediated ceRNA Network and Sample Validation.
Tang W; Lu Q; Zhu J; Zheng X; Fang N; Ji S; Lu F
Front Oncol; 2022; 12():844691. PubMed ID: 35433415
[TBL] [Abstract][Full Text] [Related]
9. Big data analysis identified a telomere-related signature predicting the prognosis and drug sensitivity in lung adenocarcinoma.
Zhang W
Medicine (Baltimore); 2023 Nov; 102(46):e35526. PubMed ID: 37986388
[TBL] [Abstract][Full Text] [Related]
10. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
Zhou J; Wang X; Li Z; Jiang R
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Five Autophagy Subtype-Related Gene Expression Pattern for Improving the Prognosis of Lung Adenocarcinoma.
Zhang MY; Huo C; Liu JY; Shi ZE; Zhang WD; Qu JJ; Yue YL; Qu YQ
Front Cell Dev Biol; 2021; 9():756911. PubMed ID: 34869345
[No Abstract] [Full Text] [Related]
12. Identification of the pyroptosis‑related prognostic gene signature and the associated regulation axis in lung adenocarcinoma.
Lin W; Chen Y; Wu B; Chen Y; Li Z
Cell Death Discov; 2021 Jun; 7(1):161. PubMed ID: 34226539
[TBL] [Abstract][Full Text] [Related]
13. Identification of N7-methylguanosine related signature for prognosis and immunotherapy efficacy prediction in lung adenocarcinoma.
Li Z; Wang W; Wu J; Ye X
Front Med (Lausanne); 2022; 9():962972. PubMed ID: 36091687
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma.
Wang Y; Xu J; Fang Y; Gu J; Zhao F; Tang Y; Xu R; Zhang B; Wu J; Fang Z; Li Y
Front Immunol; 2022; 13():950001. PubMed ID: 36091041
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.
Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y
Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis to identify a novel PTEN-associated ceRNA regulatory network as a prognostic biomarker for lung adenocarcinoma.
Xin R; Shen B; Jiang YJ; Liu JB; Li S; Hou LK; Wu W; Jia CY; Wu CY; Fu D; Ma YS; Jiang GX
Front Oncol; 2022; 12():923026. PubMed ID: 36091160
[TBL] [Abstract][Full Text] [Related]
17. Systematic Analysis and Validation of the Prognosis, Immunological Role and Biology Function of the Ferroptosis-Related lncRNA GSEC/miRNA-101-3p/CISD1 Axis in Lung Adenocarcinoma.
Jiang X; Yuan Y; Tang L; Wang J; Zhang D; Duan L
Front Mol Biosci; 2021; 8():793732. PubMed ID: 35320929
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of the molecular subtype and prognostic signature for clear cell renal cell carcinoma based on neutrophil extracellular traps.
Quan J; Huang B
Front Cell Dev Biol; 2022; 10():1021690. PubMed ID: 36523511
[No Abstract] [Full Text] [Related]
19. Bioinformatics Identification and Validation of Aging‑Related Molecular Subtype and Prognostic Signature in Sarcoma.
Hong X; Liu H; Chen C; Lai T; Lin J
Cancer Invest; 2023 May; 41(5):512-523. PubMed ID: 37130077
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel autophagy signature for predicting survival in patients with lung adenocarcinoma.
Duan J; Lei Y; Lv G; Liu Y; Zhao W; Yang Q; Su X; Song Z; Lu L; Shi Y
PeerJ; 2021; 9():e11074. PubMed ID: 33976960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
